Hussman Strategic Advisors, Inc. Bristol Myers Squibb CO Transaction History

Hussman Strategic Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$48.48 - $57.85 $1.53 Million - $1.82 Million	31,500 New	31,500 $1.62 Million
Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $1.38 Million - $1.56 Million	-25,000 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$59.92 - $68.98 $1.5 Million - $1.72 Million	25,000 New	25,000 $1.58 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.